Complex Regional Pain Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Complex Regional Pain Syndrome (CRPS) Market is Segmented by Disease Type (CRPS I, CRPS II, and CRPS-NOS), Therapy Type (Drugs, Spinal Cord Stimulation, Surgical Sympathectomy, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Complex Regional Pain Syndrome Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Complex Regional Pain Syndrome (CRPS) Market Size

Complex Regional Pain Syndrome (CRPS) Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 2.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Complex Regional Pain Syndrome (CRPS) Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Complex Regional Pain Syndrome (CRPS) Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Complex Regional Pain Syndrome (CRPS) Market Analysis

The Complex Regional Pain Syndrome Market is expected to register a CAGR of 2.1% during the forecast period.

The complex regional pain syndrome market has been significantly impacted by the COVID-19 pandemic, particularly in its early stages. COVID-19 infection causes peripheral nerve lesions, including small fiber neuropathy. The potentially disabling complication of any peripheral nerve lesion is complex regional pain syndrome (CRPS). For instance, a study report published by PubMed in November 2021, stated that systemic hyperinflammation in severe COVID-19 may contribute to peripheral and central neuronal sensitization, which may increase the risk of developing complex regional pain syndrome (CRPS). As a result of the COVID-19 effect on neuronal sensitization, the demand for drugs used in complex regional pain had witnessed a positive impact. Thus, the impact of COVID-19 on the market was adverse in its initial stages owing to supply chain constraints. However, as the pandemic has subsided, the market is expected to have stable growth during the forecast period of the study.

The major growth drivers of the complex regional pain syndrome market over the forecast period are the rising incidence of complex regional pain syndrome and the growing number of patients suffering from chronic pain. For instance, as per the study published by PubMed in September 2021, the worldwide prevalence of complex regional pain syndrome varies from 5.5 to 26.2 per 100,000 people per year. Also, as per the report published by PubMed in July 2021, the general CRPS incidence rate was 15.83 per 100,000, with 19.5 for type 1 and 12.1 for type 2. Also, the increase in chronic pain among patients influences the market growth. For instance, as per the report published by PubMed in September 2021, the prevalence of pain is 60%, 48% for chronic pain, and 10% for neuropathic pain among chronic kidney disease patients. Thus, with the significantly high incidence rate and increase of chronic pain among patients, the demand for complex regional pain syndrome treatment is expected to increase, which is anticipated to have a positive impact on the growth of the studied market during the forecast period.

Moreover, with increasing product launches the market is expected to experience growth during the forecast period of the study. For instance, in October 2021, PharmaTher Holdings Ltd. received the United States FDA orphan drug designation (ODD) for ketamine in the treatment of complex regional pain syndrome (CRPS), a rare chronic pain and inflammatory condition following an injury to a limb (arm, leg, hand or foot). 

Hence, due to the aforementioned factors such as the rising incidence of complex regional pain syndrome, the growing number of patients suffering from chronic pain, and increasing product launches, the market is expected to experience growth over the forecast period of the study. However, a lack of awareness about the target disease in developing countries is expected to restrain the complex regional pain syndrome market during the forecast period.

Complex Regional Pain Syndrome (CRPS) Industry Overview

The complex regional pain syndrome market is slightly fragmented in nature due to the presence of several companies operating globally. The major players include Abbott., Boston Scientific Corporation, GSK plc, ICU Medical, Johnson & Johnson Services, Inc., Medtronic, Viatris Inc, Nevro Corp., Purdue Pharma, and Sanofi among others. The players operating in the market focus on introducing new products to address the changing need of the patients.

Complex Regional Pain Syndrome (CRPS) Market Leaders

  1. Boston Scientific Corporation

  2. Medtronic

  3. Johnson & Johnson 

  4. Abbott

  5. Nevro Corp.

  6. *Disclaimer: Major Players sorted in no particular order
Complex Regional Pain Syndrome (CRPS) Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Complex Regional Pain Syndrome (CRPS) Market News

  • In August 2022, Abbott received approval from the United States FDA for its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy, which provides tailored relief to multiple pain areas and adds more treatment options for evolving chronic pain conditions.
  • In January 2022, Medtronic received United States FDA approval for its Intellis rechargeable neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). The Intellis rechargeable neurostimulator is also indicated for the intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with Complex Regional Pain Syndrome (CRPS).

Complex Regional Pain Syndrome (CRPS) Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Complex Regional Pain Syndrome
    • 4.2.2 Increase in Number of Patients Suffering from Chronic Pain
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness about Target Disease in Developing Countries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Disease Type
    • 5.1.1 CRPS I
    • 5.1.2 CRPS II
    • 5.1.3 CRPS-NOS
  • 5.2 By Therapy Type
    • 5.2.1 Drugs
    • 5.2.1.1 Analgesics
    • 5.2.1.2 Antidepressants
    • 5.2.1.3 Corticosteroids
    • 5.2.2 Spinal Cord Stimulation
    • 5.2.3 Surgical Sympathectomy
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 GSK plc
    • 6.1.4 ICU Medical
    • 6.1.5 Johnson & Johnson Services, Inc.
    • 6.1.6 Medtronic
    • 6.1.7 Viatris Inc
    • 6.1.8 Nevro Corp.
    • 6.1.9 Purdue Pharma
    • 6.1.10 Soin Therapeutics LLC (JanOne Inc.)
    • 6.1.11 PharmaTher Holdings Ltd.
    • 6.1.12 Sanofi
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Complex Regional Pain Syndrome (CRPS) Industry Segmentation

As per the scope of the report, complex regional pain syndrome (CRPS) is a rare debilitating disorder characterized by severe pain affecting one or more limbs. The Complex Regional Pain Syndrome (CRPS) market is segmented by Disease Type (CRPS I, CRPS II, and CRPS-NOS), Therapy Type (Drugs (Analgesics, Antidepressants, and Corticosteroids), Spinal Cord Stimulation, Surgical Sympathectomy, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Disease Type CRPS I
CRPS II
CRPS-NOS
By Therapy Type Drugs Analgesics
Antidepressants
Corticosteroids
Spinal Cord Stimulation
Surgical Sympathectomy
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Complex Regional Pain Syndrome (CRPS) Market Research FAQs

What is the current Complex Regional Pain Syndrome (CRPS) Market size?

The Complex Regional Pain Syndrome (CRPS) Market is projected to register a CAGR of 2.1% during the forecast period (2025-2030)

Who are the key players in Complex Regional Pain Syndrome (CRPS) Market?

Boston Scientific Corporation, Medtronic, Johnson & Johnson, Abbott and Nevro Corp. are the major companies operating in the Complex Regional Pain Syndrome (CRPS) Market.

Which is the fastest growing region in Complex Regional Pain Syndrome (CRPS) Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Complex Regional Pain Syndrome (CRPS) Market?

In 2025, the North America accounts for the largest market share in Complex Regional Pain Syndrome (CRPS) Market.

What years does this Complex Regional Pain Syndrome (CRPS) Market cover?

The report covers the Complex Regional Pain Syndrome (CRPS) Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Complex Regional Pain Syndrome (CRPS) Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Complex Regional Pain Syndrome Industry Report

Statistics for the 2025 Complex Regional Pain Syndrome (CRPS) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Complex Regional Pain Syndrome (CRPS) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Complex Regional Pain Syndrome Market Report Snapshots